Skip to main content
. 2022 Oct 26;44:101094. doi: 10.1016/j.gore.2022.101094

Fig. 1.

Fig. 1

Survival outcomes by stage- Stage was inversely proportional to patients’ 2-year OS rates among the entire cohort: stage I 88.0% (95% CI 83.0–93.4%), stage II 77.5% (95% CI 73.3–81.9%), stage III 54.3% (95% CI 49.2–59.9%), and stage IV 40% (95% CI 30.8–52.2%) (log rank, p < 0.001).